Literature DB >> 2540260

Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine.

M Kaschube1, G Zetler.   

Abstract

In the field-stimulated mouse vas deferens the twitch inhibiting potency of prazosin (1 microM) and alpha,beta-methylene ATP (MeATP, 10 microM) was studied, using two types of stimulation-response curves, (a) variation of frequency from 3 to 100 Hz at a constant pulse width of 0.1 ms and (b) variation of pulse width from 0.04 to 0.8 ms at a constant frequency of 15 Hz. Prazosin and MeATP reduced the twitch response by eliminating the noradrenergic and purinergic component, respectively. After the combined application of both compounds a small third twitch component remained that was most prominent at high frequencies. Reserpinization reduced the effect of prazosin but enhanced that of MeATP and increased the cholinergic component. 6-Hydroxydopamine enhanced the effects of prazosin and MeATP to the same extent, but left the cholinergic component intact. In vasa pre-loaded with [3H]-noradrenaline, field stimulation induced a larger release of tritium at high frequency and short pulse duration (100 Hz, 0.1 ms) than at lower frequency and long pulse duration (15 Hz, 0.3 ms). Prazosin (1 microM) augmented both the spontaneous and the stimulation-induced overflow of tritium, whereas MeATP (10 microM) had only a negligible negative effect on the outflow of label. In conclusion, the twitch contraction of the mouse vas deferens has a small cholinergic component in addition to the noradrenergic and purinergic components. Adrenergic and purinergic transmission seem not to run strictly in parallel: the purinergic component dominates during stimulation at low frequency and long pulse duration, and after reserpinization; 4-aminopyridine enhances the adrenergic mechanism more than the purinergic one.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540260     DOI: 10.1007/bf01244990

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  36 in total

1.  EFFECT OF DRUGS ON THE UPTAKE, RELEASE, AND METABOLISM OF H3-NOREPINEPHRINE IN THE RAT BRAIN.

Authors:  J GLOWINSKI; J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1965-07       Impact factor: 4.030

2.  Effects of acetylcholine and some other smooth muscle stimulants on the electrical and mechanical responses of the guinea-pig vas deferens to nerve stimulation.

Authors:  N O Sjöstrand
Journal:  Acta Physiol Scand       Date:  1973-09

3.  Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics.

Authors:  J Hughes; H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

4.  Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.

Authors:  R J Allcorn; T C Cunnane; K Kirkpatrick
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

5.  Actions of ATP and alpha, beta-methylene ATP on neuromuscular transmission and smooth muscle membrane of the rabbit and guinea-pig mesenteric arteries.

Authors:  S Ishikawa
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

6.  The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

7.  Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens.

Authors:  P Sneddon; D P Westfall
Journal:  J Physiol       Date:  1984-02       Impact factor: 5.182

8.  A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation.

Authors:  G Burnstock; J J Warland
Journal:  Br J Pharmacol       Date:  1987-01       Impact factor: 8.739

9.  Potentiation by cholinoceptor agonists of contractions to field stimulation of rat vas deferens.

Authors:  C M Lee
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

10.  Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors.

Authors:  A Nasseri; J F Barakeh; P W Abel; K P Minneman
Journal:  J Pharmacol Exp Ther       Date:  1985-08       Impact factor: 4.030

View more
  9 in total

1.  Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens: commentary on Jackson and Cunnane.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

2.  Investigation of neurotransmission in vas deferens from alpha(2A/D)-adrenoceptor knockout mice.

Authors:  Linda Cleary; Catherine Vandeputte; James R Docherty
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

3.  Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.

Authors:  Linda Cleary; Catherine Vandeputte; James R Docherty
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

4.  Bretylium or 6-OHDA-resistant, action potential-evoked Ca2+ transients in varicosities of the mouse vas deferens.

Authors:  V Margaret Jackson; Tom C Cunnane
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

5.  The effect of epibatidine on spontaneous and evoked neurotransmitter release in the mouse and guinea pig isolated vas deferens.

Authors:  D J Williams; K L Brain; T C Cunnane
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

6.  Comparative evaluation of lisuride and terguride, ergot alkaloid derivatives, on the field-stimulated vas deferens of mouse.

Authors:  M R Carratù; A DeSerio; D Mitolo-Chieppa; F Federico
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  The field-stimulated vas deferens of the streptozotocin-diabetic mouse: effects of prazosin, alpha, beta-methylene ATP, and variation of stimulation parameters.

Authors:  M Kaschube; H Möller-Hartmann; G Zetler
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

8.  Electrophysiological and electrochemical analysis of the secretion of ATP and noradrenaline from the sympathetic nerves in rat tail artery: effects of alpha 2-adrenoceptor agonists and antagonists and noradrenaline reuptake blockers.

Authors:  M Msghina; C Mermet; F Gonon; L Stjärne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

9.  Dynamic monitoring of NET activity in mature murine sympathetic terminals using a fluorescent substrate.

Authors:  Lauren K Parker; Julia A Shanks; James A G Kennard; Keith L Brain
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.